Werewolf Therapeutics Stock Quote HOWL - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

5.67

Bid

5.60

Ask

5.95

Volume

126,571

5.305 Day's Range 5.69

1.5735 52 Week Range 8.1939

Market Cap

237.191M

Previous Close

5.48

Open

5.45

Last Trade

112

5.67

(formt)

Last Trade Time

Financial Volume

$ 696,371

VWAP

5.5018

Average Volume (3m)

181,793

Shares Outstanding

42,737,191

Dividend Yield

PE Ratio

-6.35

Earnings Per Share (EPS)

-0.87

Revenue

19.94M

Net Profit

-37.37M

Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

werewolftx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Werewolf Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HOWL. The last closing price for Werewolf Therapeutics was $5.48. Over the last year, Werewolf Therapeutics shares have traded in a share price range of $ 1.5735 to $ 8.1939.

Werewolf Therapeutics currently has 42,737,191 shares outstanding. The market capitalization of Werewolf Therapeutics is $237.19 million. Werewolf Therapeutics has a price to earnings ratio (PE ratio) of -6.35.

Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

— Company to present an update of its ongoing monotherapy and combination Phase 1/1b trial of WTX-124 in advanced or metastatic solid tumors at ASCO — — Company plans to present interim...

Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Company to present an update of its ongoing monotherapy and combination Phase 1/1b study of WTX-124 in advanced or metastatic solid tumors WATERTOWN, Mass., April 24, 2024 (GLOBE NEWSWIRE...

Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting

First Data Demonstrating Application of PREDATOR™ Platform in Immune-Mediated Diseases WATERTOWN, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or...

Werewolf Therapeutics Presents Preclinical Results Demonstrating Anti-Tumor Effects of Pro-Inflammatory Cytokine Therapeutics WTX-518 and WTX-712 at AACR 2024 Annual Meeting

WTX-518, a conditionally activated IL-18 INDUKINETM molecule that resists suppression by IL-18BP, led to complete tumor regressions in preclinical models WTX-712, a conditionally activated IL-21...

Werewolf Therapeutics to Present First-of-Its-Kind Data Demonstrating Utility for PREDATOR™ Platform in Immunology-Based Diseases at AAI Annual Meeting

WATERTOWN, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.45	-7.35294117647	6.12	6.3415	5.305	124318	5.89611853	CS
4	0.31	5.78358208955	5.36	6.89	4.5	198087	5.79795017	CS
12	-0.3	-5.02512562814	5.97	8.1939	4.5	181793	6.19135865	CS
26	3	112.359550562	2.67	8.1939	2.0601	225235	4.91551022	CS
52	2.77	95.5172413793	2.9	8.1939	1.5735	329379	3.68024961	CS
156	-8.92	-61.1377655929	14.59	21.67	1.39	211971	4.89722706	CS
260	-12.54	-68.863261944	18.21	23.99	1.39	215144	5.14122605	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CPOPPop Culture Group Company Ltd	$ 3.11 (82.94%)	76.99M
SEZLSezzle Inc	$ 78.82 (76.17%)	779.63k
EMBCEmbecta Corporation	$ 14.18 (38.07%)	2.59M
MCRBSeres Therapeutics Inc	$ 1.02 (36.11%)	16.78M
CCSIConcensus Cloud Solutions Inc	$ 18.00 (36.05%)	1.1M
EMKREMCORE Corporation	$ 1.09 (-62.41%)	5.66M
TIVCTivic Health Systems Inc	$ 0.59 (-55.97%)	8.84M
CTMXCytomX Therapeutics Inc	$ 2.04 (-51.31%)	41.56M
RAPTRAPT Therapeutics Inc	$ 4.65 (-41.73%)	4.88M
NPCENeuropace Inc	$ 7.96 (-36.83%)	452.6k
GWAVGreenwave Technology Solutions Inc	$ 0.07 (20.48%)	189.65M
SGDSafe and Green Development Corporation	$ 0.84 (35.48%)	101.01M
SQQQProShares UltraPro Short QQQ	$ 10.68 (-0.56%)	97.21M
FFIEFaraday Future Intelligent Electric Inc	$ 0.0406 (-2.87%)	79.34M
NKLANikola Corporation	$ 0.5765 (-0.45%)	77.17M